PFA

SHR EE G AN ESH BI O - T E C H (I ND I A) L I M I TED CIN: L70101WB1982PLC121196 Reg. Office: CUBICLE NO.: 126, 3/2, 75C, PARK STREET, 3RD FLOOR KAMDHENU BUILDING, KOLKATA -700016 Email: shreeganeshbiotechindialtd@gmail.com Website: www.shreeganeshbiotech.bar Date:03.09.2026 To, To, To, Listing Department, The Secretary, Head - Listing BSE Limited, The Calcutta Stock Metropolitan Stock Exchange of P J Tower, Dalal Street Exchange Ltd, India Limited Mumbai-400001 7, Lyons Range, Vibgyor Towers, 4th floor, Plot No C Kolkata - 700001 62, Opp. Trident Hotel Bandra Kurla Complex, Bandra (E), Mumbai – 400098 Scrip Code: 539470 Scrip Code: 29221 Scrip Code: SHREEGANES Dear Sir/Madam, Sub: Submission of Notice of Annual General Meeting under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Notice of 16th Annual General Meeting of the company to be held on 28th September 2026. This is for your information and records. Thanking you, Yours Faithfully, For, SHREE GANESH BIO-TECH (INDIA) LIMITED Aman Patel Wholetime Director Encl.: As above. SHREE GANESH BIO-TECH (INDIA) LIMITED N O T I C E NOTICE is hereby given that the 16TH ANNUAL GENERAL MEETING of the Members of SHREE GANESH BIO-TECH (INDIA) LIMITED will be held at Registered office of the company CUBICLE NO.:126, 3/2, 75C, PARK STREET, 3RD FLOOR KAMDHENU BUILDING, KOLKATA - 700016 on Monday ,28th September, 2026 at 03:00 P.M. to transact the following business: ORDINARY BUSINESS: 1 To receive, consider and adopt the audited financial statements of the Company for the financial year ended March 31, 2026 and the Reports of the Board of Directors and Independent Auditors thereon; 2 To appoint a Director in place of Mr. Aman Patel (DIN: 08483544), who retires by rotation being eligible, offers himself for re-appointment. By order of the Board, Registered Office: For SHREE GANESH BIO-TECH (INDIA) LIMITED CUBICLE NO.:126,3/2 ,75C,PARK STREET,3RD FLOOR KAMDHENU BUILDING, KOLKATA- 700016 Date: 14.05.2026 AMAN PATEL Chairman DIN: 08483544 Notes: 1. A member entitled to attend and vote, is entitled to appoint a proxy to attend and vote instead of himself/ herself and the proxy need not be a member of the company. Proxies in order to be effective must be deposited at the registered office of the company in not less than 48 hours before the time fixed for the meeting. The blank proxy form is enclosed. 2. In compliance with the MCA Circulars and SEBI Circular, Notice of the AGM inter-alia, indicating the process and manner of voting through electronic means along with the Annual Report 2024-25 is being sent only through electronic mode to those Members whose e-mail addresses are registered with the Company / Depositories. Members may note that the Notice and Annual Report 2024-25 will also be available on the Company’s website, websites of the Stock Exchanges i.e. BSE Limited and on the website of NSDL. 3. Corporate Members intending to send their authorised representative to attend the Annual General Meeting are requested to send to the Company a duly certified copy of the Board Resolution authorising their representative to attend and vote at the Annual General Meeting. 4. The Register of Members and Share Transfer Register of the Company will remain closed from 21st September, 2026 to 28th September, 2026 (both days inclusive). 5. Members are requested to send their queries to the Company, if any, on accounts and operations of the Company at least seven days before the meeting so that the same could be suitably answered at the meeting. 6. To facilitate easy and cheap transactions in its shares, the Company has dematerialised its shares. Majority of the shareholders have already availed of this facility and de-materialised their shareholdings. Shareholders who have not yet de-materialised their shareholdings are requested to avail of this facility and de-materialise their shareholdings at the earliest. As per Regulation 40 of SEBI Listing Regulations, as amended, securities of listed companies can be transferred only in dematerialized form with effect from 1st April, 2019, except in case of request received for transmission or transposition of securities. In view of this and to eliminate all risks associated with physical shares and for ease of portfolio management, members holding shares in physical form are requested to consider converting their holdings to dematerialized form. Members can contact the Company or RTA for assistance in this regard. 7. The Explanatory Statement pursuant to Section 102 of the Companies Act, 2013 is annexed hereto. 8. Route map for the venue of the Annual General Meeting is given separately along with attendance slip. 9. The information or details required as per Regulation 36(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Secretarial Standard – 2 on General 1 Annual Report 2025-26 SHREE GANESH BIO-TECH (INDIA) LIMITED Meetings issued by the Institute of Company Secretaries of India, of the person seeking appointment/ re- appointment as a Director at the ensuing Annual General Meeting is as under: Name of the Director AMAN PATEL DIN 08483544 Date of Birth 29/03/1998 Nationality Indian Date of Appointment 21/03/2020 Expertise in specific functional Area and experience Operations and General Management Terms and Conditions of re-appointment along with details of Refer item no. 2 of the Notice remuneration sought to be paid Remuneration last drawn (including sitting fees, if any) Nil Directorship in other Companies (excluding Foreign, private and Section 8 Refer Corporate Governance Report companies) Membership of Committees in other Public Limited Companies Refer Corporate Governance Report No. of Shares held in the Company as on 31.03.2025 (Face Value ₹ 1/- per Nil share) Number of meetings of the Board attended during the Financial Year Refer Corporate Governance Report Relationship with other Directors, Manager and Key Managerial Personnel None of the Company Resignation from Listed Entities in past three years None THE INSTRUCTIONS FOR MEMBERS FOR REMOTE E-VOTING ARE AS UNDER The remote e-voting period begins on Friday, September 25,2026 at 09:00 A.M. and ends on Sunday, September 27,2026 at 05:00 P.M. The remote e-voting module shall be disabled by NSDL for voting thereafter. The Members, whose names appear in the Register of Members / Beneficial Owners as on the record date (cut-off date) i.e. Monday, September 21, 2026, may cast their vote electronically. The voting right of shareholders shall be in proportion to their share in the paid-up equity share capital of the Company as on the cut-off date, being Monday, September 21, 2026 How do I vote electronically using NSDL e-Voting system? The way to vote electronically on NSDL e-Voting system consists of “Two Steps” which are mentioned below: Step 1: Access to NSDL e-Voting system A) Login method for e-Voting for Individual shareholders holding securities in demat mode In terms of SEBI circular dated December 9, 2020 on e-Voting facility provided by Listed Companies, Individual shareholders holding securities in demat mode are allowed to vote through their demat account maintained with Depositories and Depository Participants. Shareholders are advised to update their mobile number and email Id in their demat accounts in order to access e-Voting facility. Login method for Individual shareholders holding securities in demat mode is given below: Type of Login Method shareholders Individual 1. For OTP based login you can click Shareholders on https://eservices.nsdl.com/SecureWeb/evoting/evotinglogin.jsp. You will have holding securities in to enter your 8-digit DP ID,8-digit Client Id, PAN No., Verification code and demat mode with generate OTP. Ente [Showing first 8,000 characters — download PDF for full document]